Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report)’s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 0.60 and traded as high as GBX 0.63. Integrated Diagnostics shares last traded at GBX 0.60, with a volume of 922,223 shares.
Integrated Diagnostics Stock Performance
The company’s fifty day simple moving average is GBX 0.60 and its 200 day simple moving average is GBX 0.63. The stock has a market capitalization of £3.49 million, a P/E ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.36. The company has a current ratio of 1.53, a quick ratio of 0.75 and a debt-to-equity ratio of 43.40.
Integrated Diagnostics Company Profile
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
See Also
- Five stocks we like better than Integrated Diagnostics
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
- 3 Under-The-Radar Small Caps Making New All-Time Highs
- 3 Ways to Target the Resources Powering AI and Data Centers
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
